跳至主要内容
临床试验/JPRN-UMIN000002009
JPRN-UMIN000002009已完成未知

The Effect of genetic polymorphism of CYP2B6 and UGT1A9 on the Pharamcokinetics and Pharmacodynamics of Propofol - The genetic polymorphism is related to pharmacodynamics of propofol

St. Marianna University School of Medicine, Department of Pharmacogenomics0 个研究点目标入组 100 人开始时间: 2009年5月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • The patients did not informed consent. The propofol administration dosage is varied. The patients are transfusion during surgical operation. The patients have infection. The patients is under the confusion, ileus, agnosis, resection of stomach, disorder of liver function, disorder of kidney function, suppress of breathing, chronic obstructive pulmonary disease, asthma, heart failure with chronic pulmonary disease, and/or seizure. The medical doctor is estimate that the patients cannot entry of study

研究者

发起方
St. Marianna University School of Medicine, Department of Pharmacogenomics

相似试验